Linked to clinical data the Urolithiasis Biobank enables the identification of biochemical risk factors in urine and blood, and supports research aiming to establish the aetiology of kidney stone disease. The collection now holds samples from over 480 kidney stone patients (Sep 2013).
To initiate the UK’s first comprehensive biobank for patients with kidney stone disease in order to facilitate world class translational research in the field of urolithiasis.
- Established 2011.
- Samples from over 480 kidney stone patients.
- Sample formats = blood, stones.
- Data Sets = demographics, clinical variables, drugs, family Hx etc
- Recruitment = Open. Aim to recruit 150 patients per year.
External researchers may access the samples and related data, however use will only be granted after formal application.
Dr Ben Turney.
Emily Grout, Research Nurse.